How to Buy Ginkgo Bioworks Holdings Stock
Ginkgo Bioworks Holdings Inc
Spinning Eagle Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Ginkgo Bioworks Holdings stock last closed at $6.83, up 1.19% from the previous day, and has decreased 12.1% in one year. It has overperformed other stocks in the Biotechnology industry by 0.15 percentage points. Ginkgo Bioworks Holdings stock is currently +36.6% from its 52-week low of $5.00, and -61.15% from its 52-week high of $17.58.
At the moment, there are 61.92M DNA shares outstanding. The market value of DNA is $422.94M. In the last 24 hours, 524,000 DNA shares were traded.
How to Buy Ginkgo Bioworks Holdings Stock
Not sure how to invest in Ginkgo Bioworks Holdings stock? Here's how.
- Figure out where to buy Ginkgo Bioworks Holdings stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Ginkgo Bioworks Holdings stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your info.
- Research Ginkgo Bioworks Holdings stock: The Ginkgo Bioworks Holdings ticker symbol is DNA. Is Ginkgo Bioworks Holdings stock a good investment? Should you buy shares of DNA? How do DNA's underlying business fundamentals look? Do top analysts think Ginkgo Bioworks Holdings is a good buy? Why has DNA's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if DNA is a good stock to buy).
- Place your DNA trade: Decide if you will purchase DNA shares at the current market price or use a limit order to buy DNA shares at a particular price.
- Get notifications regarding your DNA investment: Create a watchlist to monitor your investment in Ginkgo Bioworks Holdings shares.
Step 1: Figure out where to buy Ginkgo Bioworks Holdings stock
You need a brokerage account to access the NYSE market and buy DNA stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal info so you are able to buy DNA today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create your new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've filled out your info on app for investing, you need to deposit funds:
Watch the tutorial below for more details transferring money into your brokerage account.
Step 4: Research Ginkgo Bioworks Holdings stock
After you have identified the best place to buy Ginkgo Bioworks Holdings stock, it's crucial to research their stock prior to investing, so you actually wrap your head around the risk as well as the upside.
Ginkgo Bioworks Holdings shares quick numbers
DNA Fundamentals
WallStreetZen was built to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on DNA's stock page.
Is DNA stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge DNA's true value.
Using relative valuations methods:
- DNA could be undervalued based on its P/B ratio of 0.83x, relative to Biotechnology industry P/B ratio of 4.76x
You can do more valuation research on DNA's stock here.
DNA Financial Summary
Positive Health Checks:
- DNA has $422.62M in cash and short term investments. This is enough to cover its annual cash burn of $178.15M.
- There are more short-term assets than short-term liabilities on the DNA balance sheet.
- DNA has cash burn of 178150000. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- Total DNA debt is higher than 5 years ago, relative to shareholder equity.
- DNA profit margin has gone up by 0.57 percentage points in the past year, but the company is still unprofitable.
- There are more long-term liabilities than short-term assets on the DNA balance sheet.
- DNA has a relatively high debt to equity ratio of 1.2.
Is it a good time to buy Ginkgo Bioworks Holdings stock, according to analysts?
Out of 2 Equities analysts who give forecasts on DNA, the consensus analyst rating on Ginkgo Bioworks Holdings is a Hold
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Ginkgo Bioworks Holdings stock forecast page.
DNA Momentum
DNA Growth Metrics
Last year, DNA revenue was $170.16M. In the past 5 year, DNA's revenue has grown by 17.29% per year. This was slower than the Biotechnology industry average of 28.23%.
You can research DNA's earnings and revenue performance here.
What are DNA executives and large shareholders up to?
Over the past year, insiders at DNA have sold more shares than they have bought.
Steven P. Coen, Chief Financial Officer of DNA, was the latest DNA insider to sell. They sold $8,667.32 worth of DNA stock on Jan 20, 2026.
Learn more about who owns DNA stock here.
Can I get consistent income from DNA stock?
No, Ginkgo Bioworks Holdings doesn't provide an income stream by paying out dividends.
What others are saying about DNA
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your DNA trade
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given price limit, place a limit order.
Click the Open Trade button and eToro will execute your order.
If you want more help investing in stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your DNA investment
Now that you own some shares in DNA, you'll want to keep up with your new investment.
Make a watchlist to get the latest updates about your DNA stock.
DNA Feed
How to Buy Stock in Ginkgo Bioworks Holdings
To reiterate, here are the 6 steps to buy stock in Ginkgo Bioworks Holdings:
- Figure out where to buy Ginkgo Bioworks Holdings stock
- Create a brokerage account
- Deposit funds into your brokerage account
- Research Ginkgo Bioworks Holdings stock
- Place your DNA trade
- Get notifications regarding your DNA investment
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your new investment in Ginkgo Bioworks Holdings, add DNA to your watchlist below.
More Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.